Dergiler / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 1

Optimization and screening of solid lipid nanoparticle production for gene delivery by factorial design and response surface methodology

Sayfa
23–37
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Briefly, this methodology could be used to obtain SLNs with desired conditions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: A successful gene therapy requires a delivery system for overcoming various biological barriers.
📊
Temel Bulgular & Veri:Methods: Screening and optimization of formulations were carried out with factorial design with 3 factors and 3 levels using Box-Behnken Design.
💡
Sonuç & Katkı:Briefly, this methodology could be used to obtain SLNs with desired conditions.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Aim: A successful gene therapy requires a delivery system for overcoming various biological barriers. For this, we adapted the factorial design and response surface methodology to the cationic solid lipid nanoparticle production process. Methods: Screening and optimization of formulations were carried out with factorial design with 3 factors and 3 levels using Box-Behnken Design. Then, solid lipid nanoparticles were physicochemically characterized. Furthermore, optimal SLN formulation is examined in terms of complex formation with plasmid DNA, its protection potential against nucleases, cytotoxicity profile, and storage stability. Results: Response-surface analyses demonstrated that the selected quadratic model holds significance for particle size and zeta potential. The interaction of independent variables was statistically determined. Optimization and prediction were performed using obtained second-order polynomial equations. Optimal formulation and complexes were found to be nanosized, positively charged and their polydispersity-index values below 0.3 as an indicator of being monodispersed. Cytotoxicity of the optimal formulation is compatible for further studies and no significant increase was observed in particle size until day 21 and until day 60 for polydispersity-index. Conclusion: Optimal formulation provides a good basis as a gene delivery system was produced with developed systematic. Briefly, this methodology could be used to obtain SLNs with desired conditions.

🔖

Bu Makaleye Atıf Yap

AKBABA, H., ÖZDER, M. (2021). Optimization and screening of solid lipid nanoparticle production for gene delivery by factorial design and response surface methodology. Experimental Biomedical Research, Cilt: 4 - Sayı: 1, 23–37. https://ajindex.com/articles/201527

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Seoane‐Vazquez E, Shukla V, Rodriguez‐ Monguio R. Innovation and competition in advanced therapy medicinal products. EMBO Mol Med. 2019;11(3):1-5
  2. Ahmadi S, Rabiee N, Bagherzadeh M, et al. Stimulus-responsive sequential release systems for drug and gene delivery. Nano Today. 2020;34:100914
  3. Kogure K, Akita H, Yamada Y, et al. Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system. Adv Drug Deliv Rev. 2008;60(4- 5):559-571
  4. Zhao J, Lu D, Moya S, et al. Bispecific Tcell engager (BiTE) immunotherapy of ovarian cancer based on MIL-88A MOF/MC gene delivery system. Appl Mater Today. 2020;20:100701
  5. Büyükköröglu G, Yazan EY, Öner AF. Preparation and physicochemical characterizations of solid lipid nanoparticles containing DOTAPR ® for DNA delivery. Turk J Chem. 2015;39(5):1012-1024
  6. Gascón AR, del Pozo-Rodríguez A, Solinís MA. In: Molina FM, editor. Non-Viral Delivery Systems in Gene Therapy, Gene Therapy - Tools and Potential Applications. London: IntechOpen; 2013. p. 1-33
  7. Cevher E, Sezer AD, Çağlar ES. Gene Delivery Systems: Recent Progress in Viral and Non-Viral Therapy. In:Sezer AD, editor. Recent Advances in Novel Drug Carrier Systems. London: InTechOpen; 2012. p. 438-467
  8. Rençber S, Köse FA, Karavana SY. Dexamethasone loaded PLGA nanoparticles for potential local treatment of oral precancerous lesions. Pharm Dev Technol. 2020;25(2):149-58
  9. Limeres MJ, Suñé-Pou M, Prieto-Sánchez S, et al. Development and characterization of an improved formulation of cholesteryl oleate-loaded cationic solid-lipid nanoparticles as an efficient non-viral gene delivery system. Colloids Surf. B. 2019;184:110533
  10. Labatut AE, Mattheolabakis G. Non-viral based miR delivery and recent developments. Eur J Pharm Biopharm. 2018;128:82-90
  11. Şenyiǧit ZA, Karavana SY, Eraç B, et al. Evaluation of chitosan based vaginal bioadhesive gel formulations for antifungal drugs. Acta Pharm. 2014;64(2):139-56
  12. Das T, Venkatesh MP, Pramod-Kumar TM, et al. SLN based lendronate in situ gel as an implantable drug delivery system – A full factorial design approach. J Drug Deliv Sci Technol. 2020;55:101415
  13. Zhang M, Guo X, Wang M, et al. Tumor microenvironment-induced structure changing drug/gene delivery system for overcoming delivery-associated challenges. J Control Release. 2020;323:203-224
  14. Apaolaza PS, del Pozo-Rodríguez A, Solinís MA, et al. Structural recovery of the retina in a retinoschisin-deficient mouse